+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Pharmacovigilance & Drug Safety Software Market Research Report by Product, Clinical Trial, Distribution, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 242 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 4968703
UP TO OFF until Dec 31st 2022
The Global Pharmacovigilance & Drug Safety Software Market size was estimated at USD 426.74 million in 2021, USD 484.97 million in 2022, and is projected to grow at a CAGR 14.07% to reach USD 940.58 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Pharmacovigilance & Drug Safety Software to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market was studied across Adverse Event Reporting Software, Drug Safety Audits Software, Fully Integrated Software, and Issue Tracking Software.
  • Based on Clinical Trial, the market was studied across Phase I, Phase II, Phase III, Phase IV, and Pre-clinical.
  • Based on Distribution, the market was studied across On-Cloud and On-Premise.
  • Based on End User, the market was studied across Business Process Outsourcing Firms, Contract Research Organizations, Pharma & Biotech Companies, and Pharmacovigilance Service Providers.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across Arkansas, California, Florida, Illinois, Kentucky, Minnesota, New Jersey, New Mexico, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Pharmacovigilance & Drug Safety Software market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Pharmacovigilance & Drug Safety Software Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Pharmacovigilance & Drug Safety Software Market, including 4C Pharma Solutions, AB Cube, Accenture PLC, Advera Health Analytics, Inc., Anju Software, Inc., ArisGlobal LLC, Clinevo Technologies Private Limited, Cognizant Technology Solutions Corporation, Ennov, Ergomed PLC, Extedo GmbH, Indegene Inc., IQVIA Inc., Oracle Corporation, Sarjen Systems Private Limited, Sparta Systems, Inc., United BioSource LLC, and Wipro Limited.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Pharmacovigilance & Drug Safety Software Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pharmacovigilance & Drug Safety Software Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pharmacovigilance & Drug Safety Software Market?
4. What is the competitive strategic window for opportunities in the Global Pharmacovigilance & Drug Safety Software Market?
5. What are the technology trends and regulatory frameworks in the Global Pharmacovigilance & Drug Safety Software Market?
6. What is the market share of the leading vendors in the Global Pharmacovigilance & Drug Safety Software Market?
7. What modes and strategic moves are considered suitable for entering the Global Pharmacovigilance & Drug Safety Software Market?
Frequently Asked Questions about the Global Pharmacovigilance & Drug Safety Software Market

What is the estimated value of the Global Pharmacovigilance & Drug Safety Software Market?

The Global Pharmacovigilance & Drug Safety Software Market was estimated to be valued at $426.74 Million in 2021.

What is the growth rate of the Global Pharmacovigilance & Drug Safety Software Market?

The growth rate of the Global Pharmacovigilance & Drug Safety Software Market is 14.0%, with an estimated value of $940.58 Million by 2027.

What is the forecasted size of the Global Pharmacovigilance & Drug Safety Software Market?

The Global Pharmacovigilance & Drug Safety Software Market is estimated to be worth $940.58 Million by 2027.

Who are the key companies in the Global Pharmacovigilance & Drug Safety Software Market?

Key companies in the Global Pharmacovigilance & Drug Safety Software Market include 4C Pharma Solutions, AB Cube, Accenture PLC, Advera Health Analytics, Inc., Anju Software, Inc., ArisGlobal LLC, Clinevo Technologies Private Limited, Cognizant Technology Solutions Corporation and Ergomed PLC.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising Incidence of Adr and Drug Toxicity
5.1.1.2. Increasing Need to Reduce Time Spent Reviewing Medical Literature for Aggregate Reports and Articles
5.1.1.3. Highly Regulated Pharmacovigilance Space
5.1.2. Restraints
5.1.2.1. Expensive Deployment of Pharmacovigilance & Drug Safety Software
5.1.3. Opportunities
5.1.3.1. Increasing Investment in Research and Development (R&D) by Healthcare Companies
5.1.3.2. Integration of Ai and Machine Learning Models in Pharmacovigilance & Drug Safety Software
5.1.4. Challenges
5.1.4.1. Lack of Awareness, Training, and Underreporting of Adverse Drug Reactions (Adrs) in Developing Countries
5.2. Cumulative Impact of COVID-19
6. Pharmacovigilance & Drug Safety Software Market, by Product
6.1. Introduction
6.2. Adverse Event Reporting Software
6.3. Drug Safety Audits Software
6.4. Fully Integrated Software
6.5. Issue Tracking Software
7. Pharmacovigilance & Drug Safety Software Market, by Clinical Trial
7.1. Introduction
7.2. Phase I
7.3. Phase Ii
7.4. Phase Iii
7.5. Phase Iv
7.6. Pre-Clinical
8. Pharmacovigilance & Drug Safety Software Market, by Distribution
8.1. Introduction
8.2. On-Cloud
8.3. On-Premise
9. Pharmacovigilance & Drug Safety Software Market, by End-user
9.1. Introduction
9.2. Business Process Outsourcing Firms
9.3. Contract Research Organizations
9.4. Pharma & Biotech Companies
9.5. Pharmacovigilance Service Providers
10. Americas Pharmacovigilance & Drug Safety Software Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Pharmacovigilance & Drug Safety Software Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
12. Europe, Middle East & Africa Pharmacovigilance & Drug Safety Software Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. Competitive Landscape
13.1. Fpnv Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, by Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. 4C Pharma Solutions
14.2. Ab Cube
14.3. Accenture plc
14.4. Advera Health Analytics, Inc.
14.5. Anju Software, Inc.
14.6. Arisglobal LLC
14.7. Clinevo Technologies Private Limited
14.8. Cognizant Technology Solutions Corporation
14.9. Ennov
14.10. Ergomed plc
14.11. Extedo GmbH
14.12. Indegene Inc.
14.13. Iqvia Inc.
14.14. Oracle Corporation
14.15. Sarjen Systems Private Limited
14.16. Sparta Systems, Inc.
14.17. United Biosource LLC
14.18. Wipro Limited
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET DYNAMICS
FIGURE 8. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 9. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2027
FIGURE 11. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ADVERSE EVENT REPORTING SOFTWARE, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ADVERSE EVENT REPORTING SOFTWARE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DRUG SAFETY AUDITS SOFTWARE, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DRUG SAFETY AUDITS SOFTWARE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY FULLY INTEGRATED SOFTWARE, 2019-2027 (USD MILLION)
FIGURE 16. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY FULLY INTEGRATED SOFTWARE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ISSUE TRACKING SOFTWARE, 2019-2027 (USD MILLION)
FIGURE 18. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ISSUE TRACKING SOFTWARE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 19. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2021 VS 2027 (%)
FIGURE 20. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2021 VS 2027 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2027
FIGURE 22. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHASE I, 2019-2027 (USD MILLION)
FIGURE 23. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHASE I, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 24. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHASE II, 2019-2027 (USD MILLION)
FIGURE 25. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHASE II, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 26. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHASE III, 2019-2027 (USD MILLION)
FIGURE 27. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHASE III, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 28. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHASE IV, 2019-2027 (USD MILLION)
FIGURE 29. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHASE IV, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 30. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRE-CLINICAL, 2019-2027 (USD MILLION)
FIGURE 31. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRE-CLINICAL, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 32. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2021 VS 2027 (%)
FIGURE 33. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2021 VS 2027 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2027
FIGURE 35. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ON-CLOUD, 2019-2027 (USD MILLION)
FIGURE 36. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ON-CLOUD, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 37. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ON-PREMISE, 2019-2027 (USD MILLION)
FIGURE 38. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ON-PREMISE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 39. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 40. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2021 VS 2027 (USD MILLION)
FIGURE 41. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2027
FIGURE 42. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY BUSINESS PROCESS OUTSOURCING FIRMS, 2019-2027 (USD MILLION)
FIGURE 43. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY BUSINESS PROCESS OUTSOURCING FIRMS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 44. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2019-2027 (USD MILLION)
FIGURE 45. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 46. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, 2019-2027 (USD MILLION)
FIGURE 47. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 48. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHARMACOVIGILANCE SERVICE PROVIDERS, 2019-2027 (USD MILLION)
FIGURE 49. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHARMACOVIGILANCE SERVICE PROVIDERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 50. AMERICAS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 51. AMERICAS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 52. AMERICAS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 53. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY COUNTRY, 2027
FIGURE 54. ARGENTINA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 55. BRAZIL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. CANADA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. MEXICO PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. UNITED STATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 59. UNITED STATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 60. UNITED STATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 61. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY STATE, 2027
FIGURE 62. ASIA-PACIFIC PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. ASIA-PACIFIC PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 64. ASIA-PACIFIC PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 65. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY COUNTRY, 2027
FIGURE 66. AUSTRALIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 67. CHINA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 68. INDIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 69. INDONESIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 70. JAPAN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 71. MALAYSIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 72. PHILIPPINES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 73. SINGAPORE PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 74. SOUTH KOREA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 75. TAIWAN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 76. THAILAND PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 77. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 78. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 79. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 80. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY COUNTRY, 2027
FIGURE 81. FRANCE PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 82. GERMANY PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 83. ITALY PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 84. NETHERLANDS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 85. QATAR PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 86. RUSSIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 87. SAUDI ARABIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 88. SOUTH AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 89. SPAIN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 90. UNITED ARAB EMIRATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 91. UNITED KINGDOM PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 92. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 93. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 94. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 6. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ADVERSE EVENT REPORTING SOFTWARE, BY REGION, 2019-2027 (USD MILLION)
TABLE 7. AMERICAS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ADVERSE EVENT REPORTING SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ADVERSE EVENT REPORTING SOFTWARE, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. ASIA-PACIFIC PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ADVERSE EVENT REPORTING SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ADVERSE EVENT REPORTING SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DRUG SAFETY AUDITS SOFTWARE, BY REGION, 2019-2027 (USD MILLION)
TABLE 12. AMERICAS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DRUG SAFETY AUDITS SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DRUG SAFETY AUDITS SOFTWARE, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. ASIA-PACIFIC PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DRUG SAFETY AUDITS SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DRUG SAFETY AUDITS SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY FULLY INTEGRATED SOFTWARE, BY REGION, 2019-2027 (USD MILLION)
TABLE 17. AMERICAS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY FULLY INTEGRATED SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY FULLY INTEGRATED SOFTWARE, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. ASIA-PACIFIC PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY FULLY INTEGRATED SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 20. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY FULLY INTEGRATED SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ISSUE TRACKING SOFTWARE, BY REGION, 2019-2027 (USD MILLION)
TABLE 22. AMERICAS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ISSUE TRACKING SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 23. UNITED STATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ISSUE TRACKING SOFTWARE, BY STATE, 2019-2027 (USD MILLION)
TABLE 24. ASIA-PACIFIC PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ISSUE TRACKING SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 25. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ISSUE TRACKING SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2019-2027 (USD MILLION)
TABLE 27. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHASE I, BY REGION, 2019-2027 (USD MILLION)
TABLE 28. AMERICAS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHASE I, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. UNITED STATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHASE I, BY STATE, 2019-2027 (USD MILLION)
TABLE 30. ASIA-PACIFIC PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHASE I, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHASE I, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 32. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHASE II, BY REGION, 2019-2027 (USD MILLION)
TABLE 33. AMERICAS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHASE II, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 34. UNITED STATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHASE II, BY STATE, 2019-2027 (USD MILLION)
TABLE 35. ASIA-PACIFIC PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHASE II, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 36. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHASE II, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 37. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHASE III, BY REGION, 2019-2027 (USD MILLION)
TABLE 38. AMERICAS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHASE III, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 39. UNITED STATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHASE III, BY STATE, 2019-2027 (USD MILLION)
TABLE 40. ASIA-PACIFIC PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHASE III, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 41. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHASE III, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 42. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHASE IV, BY REGION, 2019-2027 (USD MILLION)
TABLE 43. AMERICAS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHASE IV, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 44. UNITED STATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHASE IV, BY STATE, 2019-2027 (USD MILLION)
TABLE 45. ASIA-PACIFIC PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHASE IV, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 46. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHASE IV, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 47. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRE-CLINICAL, BY REGION, 2019-2027 (USD MILLION)
TABLE 48. AMERICAS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRE-CLINICAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 49. UNITED STATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRE-CLINICAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 50. ASIA-PACIFIC PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRE-CLINICAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 51. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRE-CLINICAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 52. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 53. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ON-CLOUD, BY REGION, 2019-2027 (USD MILLION)
TABLE 54. AMERICAS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ON-CLOUD, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 55. UNITED STATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ON-CLOUD, BY STATE, 2019-2027 (USD MILLION)
TABLE 56. ASIA-PACIFIC PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ON-CLOUD, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ON-CLOUD, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 58. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ON-PREMISE, BY REGION, 2019-2027 (USD MILLION)
TABLE 59. AMERICAS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ON-PREMISE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 60. UNITED STATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ON-PREMISE, BY STATE, 2019-2027 (USD MILLION)
TABLE 61. ASIA-PACIFIC PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ON-PREMISE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 62. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY ON-PREMISE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 63. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 64. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY BUSINESS PROCESS OUTSOURCING FIRMS, BY REGION, 2019-2027 (USD MILLION)
TABLE 65. AMERICAS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY BUSINESS PROCESS OUTSOURCING FIRMS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 66. UNITED STATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY BUSINESS PROCESS OUTSOURCING FIRMS, BY STATE, 2019-2027 (USD MILLION)
TABLE 67. ASIA-PACIFIC PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY BUSINESS PROCESS OUTSOURCING FIRMS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY BUSINESS PROCESS OUTSOURCING FIRMS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 69. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2019-2027 (USD MILLION)
TABLE 70. AMERICAS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 71. UNITED STATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY STATE, 2019-2027 (USD MILLION)
TABLE 72. ASIA-PACIFIC PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 74. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 75. AMERICAS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 76. UNITED STATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 77. ASIA-PACIFIC PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 79. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHARMACOVIGILANCE SERVICE PROVIDERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 80. AMERICAS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHARMACOVIGILANCE SERVICE PROVIDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 81. UNITED STATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHARMACOVIGILANCE SERVICE PROVIDERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 82. ASIA-PACIFIC PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHARMACOVIGILANCE SERVICE PROVIDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PHARMACOVIGILANCE SERVICE PROVIDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 84. AMERICAS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 85. AMERICAS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 86. AMERICAS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 87. AMERICAS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2019-2027 (USD MILLION)
TABLE 88. AMERICAS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 89. AMERICAS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 90. ARGENTINA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 91. ARGENTINA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 92. ARGENTINA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2019-2027 (USD MILLION)
TABLE 93. ARGENTINA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 94. ARGENTINA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 95. BRAZIL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 96. BRAZIL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 97. BRAZIL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2019-2027 (USD MILLION)
TABLE 98. BRAZIL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 99. BRAZIL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 100. CANADA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 101. CANADA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 102. CANADA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2019-2027 (USD MILLION)
TABLE 103. CANADA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 104. CANADA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 105. MEXICO PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 106. MEXICO PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 107. MEXICO PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2019-2027 (USD MILLION)
TABLE 108. MEXICO PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 109. MEXICO PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 110. UNITED STATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 111. UNITED STATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 112. UNITED STATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 113. UNITED STATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2019-2027 (USD MILLION)
TABLE 114. UNITED STATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 115. UNITED STATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 116. ASIA-PACIFIC PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 117. ASIA-PACIFIC PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 118. ASIA-PACIFIC PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 119. ASIA-PACIFIC PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2019-2027 (USD MILLION)
TABLE 120. ASIA-PACIFIC PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 121. ASIA-PACIFIC PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 122. AUSTRALIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 123. AUSTRALIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 124. AUSTRALIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2019-2027 (USD MILLION)
TABLE 125. AUSTRALIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 126. AUSTRALIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 127. CHINA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 128. CHINA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 129. CHINA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2019-2027 (USD MILLION)
TABLE 130. CHINA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 131. CHINA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 132. INDIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 133. INDIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 134. INDIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2019-2027 (USD MILLION)
TABLE 135. INDIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 136. INDIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 137. INDONESIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 138. INDONESIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 139. INDONESIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2019-2027 (USD MILLION)
TABLE 140. INDONESIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 141. INDONESIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 142. JAPAN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 143. JAPAN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 144. JAPAN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2019-2027 (USD MILLION)
TABLE 145. JAPAN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 146. JAPAN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 147. MALAYSIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 148. MALAYSIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 149. MALAYSIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2019-2027 (USD MILLION)
TABLE 150. MALAYSIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 151. MALAYSIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 152. PHILIPPINES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 153. PHILIPPINES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 154. PHILIPPINES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2019-2027 (USD MILLION)
TABLE 155. PHILIPPINES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 156. PHILIPPINES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 157. SINGAPORE PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 158. SINGAPORE PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 159. SINGAPORE PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2019-2027 (USD MILLION)
TABLE 160. SINGAPORE PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 161. SINGAPORE PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 162. SOUTH KOREA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 163. SOUTH KOREA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 164. SOUTH KOREA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2019-2027 (USD MILLION)
TABLE 165. SOUTH KOREA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 166. SOUTH KOREA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 167. TAIWAN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 168. TAIWAN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 169. TAIWAN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2019-2027 (USD MILLION)
TABLE 170. TAIWAN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 171. TAIWAN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 172. THAILAND PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 173. THAILAND PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 174. THAILAND PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2019-2027 (USD MILLION)
TABLE 175. THAILAND PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 176. THAILAND PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2019-2027 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 183. FRANCE PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 184. FRANCE PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 185. FRANCE PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2019-2027 (USD MILLION)
TABLE 186. FRANCE PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 187. FRANCE PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 188. GERMANY PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 189. GERMANY PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 190. GERMANY PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2019-2027 (USD MILLION)
TABLE 191. GERMANY PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 192. GERMANY PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 193. ITALY PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 194. ITALY PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 195. ITALY PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2019-2027 (USD MILLION)
TABLE 196. ITALY PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 197. ITALY PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 198. NETHERLANDS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 199. NETHERLANDS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 200. NETHERLANDS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2019-2027 (USD MILLION)
TABLE 201. NETHERLANDS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 202. NETHERLANDS PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 203. QATAR PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 204. QATAR PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 205. QATAR PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2019-2027 (USD MILLION)
TABLE 206. QATAR PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 207. QATAR PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 208. RUSSIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 209. RUSSIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 210. RUSSIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2019-2027 (USD MILLION)
TABLE 211. RUSSIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 212. RUSSIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 213. SAUDI ARABIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 214. SAUDI ARABIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 215. SAUDI ARABIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2019-2027 (USD MILLION)
TABLE 216. SAUDI ARABIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 217. SAUDI ARABIA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 218. SOUTH AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 219. SOUTH AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 220. SOUTH AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2019-2027 (USD MILLION)
TABLE 221. SOUTH AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 222. SOUTH AFRICA PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 223. SPAIN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 224. SPAIN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 225. SPAIN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2019-2027 (USD MILLION)
TABLE 226. SPAIN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 227. SPAIN PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2019-2027 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 233. UNITED KINGDOM PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 234. UNITED KINGDOM PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 235. UNITED KINGDOM PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY CLINICAL TRIAL, 2019-2027 (USD MILLION)
TABLE 236. UNITED KINGDOM PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 237. UNITED KINGDOM PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 238. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 239. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 240. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 241. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET RANKING
TABLE 242. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET SHARE, BY KEY PLAYER, 2021
TABLE 243. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET MERGER & ACQUISITION
TABLE 244. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 245. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 246. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET INVESTMENT & FUNDING
TABLE 247. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 248. GLOBAL PHARMACOVIGILANCE & DRUG SAFETY SOFTWARE MARKET: LICENSE & PRICING

Companies Mentioned

  • 4C Pharma Solutions
  • AB Cube
  • Accenture PLC
  • Advera Health Analytics, Inc.
  • Anju Software, Inc.
  • ArisGlobal LLC
  • Clinevo Technologies Private Limited
  • Cognizant Technology Solutions Corporation
  • Ennov
  • Ergomed PLC
  • Extedo GmbH
  • Indegene Inc.
  • IQVIA Inc.
  • Oracle Corporation
  • Sarjen Systems Private Limited
  • Sparta Systems, Inc.
  • United BioSource LLC
  • Wipro Limited

Methodology

Loading
LOADING...